Biohaven .(BHVN)
Search documents
Biohaven .(BHVN) - 2020 Q2 - Earnings Call Transcript
2020-08-10 18:48
Biohaven Pharmaceutical Holding Company Ltd (NYSE:BHVN) Q2 2020 Earnings Conference Call August 10, 2020 8:00 AM ET Company Participants Clifford Bechtold - COO Vladimir Coric - CEO & Director James Engelhart - CFO & Treasurer William Jones - Chief Commercial Officer, Migraine & Common Diseases Elyse Stock - Chief Medical Officer Conference Call Participants Paul Choi - Goldman Sachs Group Charles Duncan - Cantor Fitzgerald & Co. Ken Cacciatore - Cowen and Company Laura Chico - Wedbush Securities Timothy Lu ...
Biohaven Pharmaceutical (BHVN) Investor Presentation - Slideshow
2020-08-10 16:40
neuroinnovation Meeting Patient Needs Growing Value INVESTOR PRESENTATION | AUG 2020 NYSE: BHVN © 2020 Biohaven Pharmaceuticals Inc. All rights reserved. Disclaimer This presentation contains forward-looking statements within the meaning of "safe harbor" provisions of The Private Securities Litigation Reform Act of 1995, including: statements about Biohaven Pharmaceutical Holding Company Ltd. (The "Company") and our plans to develop and commercialize our product candidates, our planned clinical trials for o ...
Biohaven .(BHVN) - 2020 Q2 - Earnings Call Presentation
2020-08-10 16:39
August 10, 2020 2nd Quarter 2020 Earnings Ellie, living with migraine © 2020 Biohaven Pharmaceuticals. All rights reserved. NYSE:BHVN Cliff Bechtold, M.S. | Chief Operating Officer Opening Remarks Agenda 3 Opening Remarks | Cliff Bechtold, M.S. Chief Operating Officer Quarter Summary and Recent Events | Vlad Coric, M.D. Chief Executive Officer 2Q20 Financial Results | Jim Englehart, C.P.A. Chief Financial Officer Commercial Events | BJ Jones, Chief Commercial Officer Migraine and Common Disease R&D Update | ...
Biohaven Pharmaceutical (BHVN) Presents At American Academy of Neurology Annual Meeting - Slideshow
2019-05-10 21:04
INDEPENDENCI FROM MIGRAINI Please join Biohaven for an informative Investor and Clinician dinner as leading experts discuss the advancement of the Biohaven NOJECTION™ CGRP antagonist platform. TIME 6:30PM Registration 7:00PM Presentation DATE Tuesday, May 7th, 2019 LOCATION The Rittenhouse Hotel 210 W. Rittenhouse Square Ballroom North, Philadelphia, PA Guest Speakers: Richard Lipton, MD Albert Einstein College of Medicine Montefiore Headache Center David Kudrow, MD California Medical Clinic for Headache Je ...